
Efinaconazole - Cas No. 164650-44-6, 99% Min Purity, Pharmaceutical Grade Solid | White Solid, Triazole Antifungal For Onychomycosis Treatment
Get Latest Price
Minimum Order Quantity :
1g
In Stock
Product Specifications
| Grade | Medicine Grade |
| Usage | Efinaconazole is a triazole antifungal. It is approved for use in Canada and the USA as a 10% topical solution for the treatment of onychomycosis (fungal infection of the nail).[1][2] Efinaconazole acts as a 14I -demethylase inhibitor. |
| Storage | Freezer |
| CAS No | 164650-44-6 |
| Appearance | white solid |
| Type | Other |
| Form | Solid |
| Purity | 99%min |
| Place of Origin | China |
| Molecular Formula | C18H22F2N4O |
| Molecular Weight | 348.39 Grams (g) |
| Other Names | KP 103;Efinaconazole;(alphaR,betaR)-alpha-(2,4-Difluorophenyl)-beta-methyl-4-methylene-alpha-(1H-1,2,4-triazol-1-ylmethyl)-1-piperidineethanol;KP 103 (pharmaceutical); |
| Application | Pharmaceutical Industry |
| Payment Terms | Telegraphic Transfer (T/T) |
| Supply Ability | 400kg Per Day |
| Sample Available | 1 |
| Main Export Market(s) | Asia |
| Packaging Details | foil/bag/bottle |
| Delivery Time | ship immediately after confirmation if there have material in stock Days |
| Sample Policy | Contact us for information regarding our sample policy |
| FOB Port | Shanghai |
| GSTIN | 0% |
Product Overview
Key Features
Company Details
Focusing on a customer-centric approach, CHEMVON BIOTECHNOLOGY (SHANGHAI) CO. LTD. has a pan-India presence and caters to a huge consumer base throughout the country. Buy Chemical Supplies in bulk from CHEMVON BIOTECHNOLOGY (SHANGHAI) CO. LTD. at Trade India quality-assured products.
Business Type
Exporter, Manufacturer, Distributor, Supplier, Trading Company
Employee Count
250
Establishment
2004
Working Days
Monday To Sunday
Related Products
Explore Related Categories
More Products From This Seller
Seller Details
Shanghai, Shanghai
CEO
Mr. Peter Dong Wang
Address
Suite B-10, Chuansha Road 6999#, Shanghai, Shanghai, 201203, China
chemical compound in Shanghai
Report incorrect details










































